Klementina ÖsterbergChairman of the board
Klementina is CEO of GU Holding, the holding company of University of Gothenburg which invests in the commercialization of innovations. Klementina has a background in Business Administration and Economics and has worked with financing, company start-ups and management. She holds several board engagements. Previous assignments include the business plan competition Venture Cup, different Volvo companies, Daimler Chrysler and Geveko Industries.
Elisabet Litsmark-NordenstamChairman for the MIVAC Research Centre
Elisabet is also chairman for the MIVAC Research Centre, University of Gothenburg. She holds a Bachelor of Arts from University of Gothenburg and a M.Sc. in Management from Massachusetts Institute of Technology, Cambridge, Massachusetts, USA, and is self employed as the CEO for Elitor AB. Elisabet has a long experience of senior management positions within both private enterprises as well as within the public service sector. She has several board engagements and has also been vice chairman of the board for University of Gothenburg.
Ola RönnBoard member
Ola has an MD and Ph.D. from University of Gothenburg and is a specialist in Internal Medicine and was appointed Associate Professor of Medicine at the same university. After a long career in academic medicine Ola joined the pharmaceutical industry. He then worked at Hoechst-Roussel, Kabi-Pharmacia and Pharmacia Upjohn in different senior R&D positions. The last 10 years Ola has worked for AstraZeneca first as site head of clinical and Global Director of Drug Safety and then as Vice President and Head of the Gastrointestinal Therapy Area and Vice President Gastrointestinal Scientific Affairs up to his retirement from AZ. Ola is now working as an independent consultant mainly for the pharma industry and is a board member of several R&D related institutions.
Nils LyckeBoard member
Nils, MD, Ph.D., Professor and Chief Physician at the department of Microbiology and Immunology at University of Gothenburg. Nils is the inventor of the Re-TolerogenTM platform, previously developed within MIVAC Development and now spun-out to Toleranzia AB. He is currently Head of MIVAC center-of-excellence at University of Gothenburg. Nils also works as scientific advisor both to the pharmaceutical industry as well as to various grant offices. He has a strong academic background in preclinical and clinical disciplines and a long experience of different EU-projects both as partner and coordinator.
Jan PilebjerBoard member (alternate)
Jan Pilebjer, born in 1954, has an economics degree from Uppsala University and is a business developer at GU Ventures. Pilebjer is a board alternate of Toleranzia since 2014. Pilebjer has extensive experience in international senior roles within both pharmaceutical and biotechnology companies such as Nycomed, Medirox, Biopool, Baxter, Kabi Vitrum and Upjohn